{"id":799988,"date":"2025-01-13T08:18:09","date_gmt":"2025-01-13T13:18:09","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/aditxts-board-of-directors-unanimously-approve-positioning-pearsanta-for-ipo-to-support-global-launch-of-its-early-cancer-detection-platform\/"},"modified":"2025-01-13T08:18:09","modified_gmt":"2025-01-13T13:18:09","slug":"aditxts-board-of-directors-unanimously-approve-positioning-pearsanta-for-ipo-to-support-global-launch-of-its-early-cancer-detection-platform","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/aditxts-board-of-directors-unanimously-approve-positioning-pearsanta-for-ipo-to-support-global-launch-of-its-early-cancer-detection-platform\/","title":{"rendered":"Aditxt\u2019s Board of Directors Unanimously Approve Positioning Pearsanta for IPO to Support Global Launch of its Early Cancer Detection Platform"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }\n.bwuline { text-decoration: underline }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>Aditxt\u2019s Board of Directors Unanimously Approve Positioning Pearsanta for IPO to Support Global Launch of its Early Cancer Detection Platform<\/b><\/p>\n<p>MOUNTAIN VIEW, Calif.&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nAditxt, Inc. (NASDAQ: ADTX) (\u201cAditxt\u201d or the \u201cCompany\u201d), a social innovation platform dedicated to accelerating promising health innovations, is pleased to announce that its Board of Directors has authorized management to explore taking its subsidiary, Pearsanta, Inc. (\u201cPearsanta\u201d), public via a proposed initial public offering (\u201cIPO\u201d) in 2025. This decision aligns with Aditxt&#8217;s mission to secure and develop transformative health innovations, positioning them for accelerated growth and broader market impact.<\/p>\n<p>\nPearsanta, a precision diagnostic company, has advanced its development and operational capabilities, particularly in early cancer detection, by leveraging its proprietary Mitomic<sup>\u00ae <\/sup>Technology platform. The proposed Pearsanta IPO is intended to provide critical resources to accelerate Pearsanta\u2019s growth and expand its market presence.<\/p>\n<p>\n\u201cCancer remains to be one of humanities biggest health challenges. Pearsanta\u2019s launch of its Mitomic<sup>\u00ae <\/sup>Technology platform for the early detection of cancer, reflects our commitment to identifying, developing and accelerating some of the most promising health innovations,\u201d said Amro Albanna, Co-Founder, Chairman, and CEO of Aditxt. \u201cThe Board\u2019s authorization to explore this path is a key first step in positioning Pearsanta for a successful global launch.\u201d<\/p>\n<p>\n\u201cThe proposed IPO marks a transformative moment for Pearsanta as we seek to bring our groundbreaking Mitomic\u00ae Technology platform to the global stage. We believe this milestone will enable us to accelerate the commercialization of our early cancer detection solutions, empowering clinicians with tools for earlier and more accurate diagnoses,\u201d said Chris Mitton, President of Pearsanta. \u201cOur focus remains on addressing critical unmet needs in healthcare, and this step is intended to position us to make a meaningful impact in the fight against cancer worldwide.\u201d<\/p>\n<p><b>About Aditxt<\/b><\/p>\n<p>\nAditxt, Inc.\u00ae is a social innovation platform dedicated to accelerating promising health innovations. Aditxt\u2019s ecosystem of research institutions, industry partners, and shareholders collaboratively drives their mission to &#8220;Make Promising Innovations Possible Together.&#8221; The innovation platform is the cornerstone of Aditxt\u2019s strategy, where multiple disciplines drive disruptive growth and address significant societal challenges. Aditxt operates a unique model that democratizes innovation, ensures every stakeholder\u2019s voice is heard and valued, and empowers collective progress.<\/p>\n<p>\nAditxt currently operates two programs focused on immune health and precision health. The Company plans to introduce two additional programs dedicated to public health and women\u2019s health. For these, Aditxt has entered into an Arrangement Agreement with Appili Therapeutics, Inc. (&#8220;Appili&#8221;) (TSX: APLI; OTCPink: APLIF), which focuses on infectious diseases, and a Merger Agreement with Evofem Biosciences, Inc. (&#8220;Evofem&#8221;) (OTCQB: EVFM). Each program will be designed to function autonomously while collectively advancing Aditxt\u2019s mission of discovering, developing, and deploying innovative health solutions to tackle some of the most urgent health challenges. The closing of each of the transactions with Appili and Evofem is subject to several conditions, including but not limited to approval of the transactions by the respective target shareholders and Aditxt raising sufficient capital to fund its obligations at closing. These obligations include cash payments of approximately $17 million for Appili and $17 million for Evofem, which includes approximately $15.2 million required to satisfy Evofem&#8217;s senior secured noteholder; should Aditxt fail to secure these funds, Evofem&#8217;s senior secured noteholder is expected to seek to prevent the closing of the merger with Evofem. On December 23, 2024, Evofem announced the cancellation of its special stockholders meeting and the withdrawal of the merger proposal with Aditxt from consideration by the stockholders. No assurance can be provided that all of the conditions to closing will be obtained or satisfied or that either of the transactions will ultimately close.<\/p>\n<p>\nFor more information, <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.aditxt.com&amp;esheet=54178010&amp;newsitemid=20250113994472&amp;lan=en-US&amp;anchor=www.aditxt.com&amp;index=1&amp;md5=c42991cf29994d2a7012781343dc0167\">www.aditxt.com<\/a>.<\/p>\n<p><b>About Pearsanta<\/b><\/p>\n<p>\nPearsanta is at the forefront of precision health, focusing on early cancer detection through advanced diagnostic technologies. Its proprietary Mitomic Technology Platform leverages the unique properties of mitochondrial DNA to detect cancer and other diseases with high accuracy via non-invasive, blood-based liquid biopsy tests. Pearsanta&#8217;s asset portfolio also includes a range of other innovative diagnostic technologies, all aimed at transforming early disease detection and monitoring, enabling more informed treatment decisions, and ultimately improving patient outcomes.<\/p>\n<p><b>Forward-Looking Statements<\/b><\/p>\n<p>\nCertain statements in this press release constitute &#8220;forward-looking statements&#8221; within the meaning of federal securities laws. Forward-looking statements include statements regarding the Company\u2019s intentions, beliefs, projections, outlook, analyses, or current expectations concerning, among other things, the Company\u2019s ongoing and planned product and business development; the Company\u2019s ability to finance and execute its strategic M&amp;A initiatives; the Company\u2019s ability to obtain the necessary funding and partner to commence clinical trials; the Company\u2019s intellectual property position; the Company\u2019s ability to develop commercial functions; expectations regarding product launch and revenue; the Company\u2019s results of operations, cash needs, spending, financial condition, liquidity, prospects, growth, and strategies; the Company\u2019s ability to raise additional capital; expected usage of the Company\u2019s ELOC and ATM facilities; the industry in which the Company operates; and the trends that may affect the industry or the Company. Forward-looking statements are not guarantees of future performance, and actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, as well as market and other conditions and those risks more fully discussed in the section titled &#8220;Risk Factors&#8221; in Aditxt\u2019s most recent Annual Report on Form 10-K, as well as discussions of potential risks, uncertainties, and other important factors in the Company\u2019s other filings with the Securities and Exchange Commission. All such statements speak only as of the date made, and the Company undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250113994472r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20250113994472\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20250113994472\/en\/<\/a><\/span><\/p>\n<p><b><span class=\"bwuline\">Aditxt, Inc.<br \/>\n<\/span><\/b><br \/>Corporate Communications<br \/>\n<br \/>Jeff Ramson, PCG Advisory, Inc.<br \/>\n<br \/>T: 646-863-6893<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:contactus@aditxt.com\">contactus@aditxt.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> California United States North America<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Biotechnology Health Pharmaceutical Health Technology Oncology<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\" \/>\n","protected":false},"excerpt":{"rendered":"<p>Aditxt\u2019s Board of Directors Unanimously Approve Positioning Pearsanta for IPO to Support Global Launch of its Early Cancer Detection Platform MOUNTAIN VIEW, Calif.&#8211;(BUSINESS WIRE)&#8211; Aditxt, Inc. (NASDAQ: ADTX) (\u201cAditxt\u201d or the \u201cCompany\u201d), a social innovation platform dedicated to accelerating promising health innovations, is pleased to announce that its Board of Directors has authorized management to explore taking its subsidiary, Pearsanta, Inc. (\u201cPearsanta\u201d), public via a proposed initial public offering (\u201cIPO\u201d) in 2025. This decision aligns with Aditxt&#8217;s mission to secure and develop transformative health innovations, positioning them for accelerated growth and broader market impact. Pearsanta, a precision diagnostic company, has advanced its development and operational capabilities, particularly in early cancer detection, by leveraging its proprietary Mitomic\u00ae Technology platform. The proposed &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/aditxts-board-of-directors-unanimously-approve-positioning-pearsanta-for-ipo-to-support-global-launch-of-its-early-cancer-detection-platform\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Aditxt\u2019s Board of Directors Unanimously Approve Positioning Pearsanta for IPO to Support Global Launch of its Early Cancer Detection Platform&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-799988","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Aditxt\u2019s Board of Directors Unanimously Approve Positioning Pearsanta for IPO to Support Global Launch of its Early Cancer Detection Platform - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/aditxts-board-of-directors-unanimously-approve-positioning-pearsanta-for-ipo-to-support-global-launch-of-its-early-cancer-detection-platform\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Aditxt\u2019s Board of Directors Unanimously Approve Positioning Pearsanta for IPO to Support Global Launch of its Early Cancer Detection Platform - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Aditxt\u2019s Board of Directors Unanimously Approve Positioning Pearsanta for IPO to Support Global Launch of its Early Cancer Detection Platform MOUNTAIN VIEW, Calif.&#8211;(BUSINESS WIRE)&#8211; Aditxt, Inc. (NASDAQ: ADTX) (\u201cAditxt\u201d or the \u201cCompany\u201d), a social innovation platform dedicated to accelerating promising health innovations, is pleased to announce that its Board of Directors has authorized management to explore taking its subsidiary, Pearsanta, Inc. (\u201cPearsanta\u201d), public via a proposed initial public offering (\u201cIPO\u201d) in 2025. This decision aligns with Aditxt&#8217;s mission to secure and develop transformative health innovations, positioning them for accelerated growth and broader market impact. Pearsanta, a precision diagnostic company, has advanced its development and operational capabilities, particularly in early cancer detection, by leveraging its proprietary Mitomic\u00ae Technology platform. The proposed &hellip; Continue reading &quot;Aditxt\u2019s Board of Directors Unanimously Approve Positioning Pearsanta for IPO to Support Global Launch of its Early Cancer Detection Platform&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/aditxts-board-of-directors-unanimously-approve-positioning-pearsanta-for-ipo-to-support-global-launch-of-its-early-cancer-detection-platform\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-01-13T13:18:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250113994472r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aditxts-board-of-directors-unanimously-approve-positioning-pearsanta-for-ipo-to-support-global-launch-of-its-early-cancer-detection-platform\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aditxts-board-of-directors-unanimously-approve-positioning-pearsanta-for-ipo-to-support-global-launch-of-its-early-cancer-detection-platform\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Aditxt\u2019s Board of Directors Unanimously Approve Positioning Pearsanta for IPO to Support Global Launch of its Early Cancer Detection Platform\",\"datePublished\":\"2025-01-13T13:18:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aditxts-board-of-directors-unanimously-approve-positioning-pearsanta-for-ipo-to-support-global-launch-of-its-early-cancer-detection-platform\\\/\"},\"wordCount\":1027,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aditxts-board-of-directors-unanimously-approve-positioning-pearsanta-for-ipo-to-support-global-launch-of-its-early-cancer-detection-platform\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20250113994472r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aditxts-board-of-directors-unanimously-approve-positioning-pearsanta-for-ipo-to-support-global-launch-of-its-early-cancer-detection-platform\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aditxts-board-of-directors-unanimously-approve-positioning-pearsanta-for-ipo-to-support-global-launch-of-its-early-cancer-detection-platform\\\/\",\"name\":\"Aditxt\u2019s Board of Directors Unanimously Approve Positioning Pearsanta for IPO to Support Global Launch of its Early Cancer Detection Platform - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aditxts-board-of-directors-unanimously-approve-positioning-pearsanta-for-ipo-to-support-global-launch-of-its-early-cancer-detection-platform\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aditxts-board-of-directors-unanimously-approve-positioning-pearsanta-for-ipo-to-support-global-launch-of-its-early-cancer-detection-platform\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20250113994472r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2025-01-13T13:18:09+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aditxts-board-of-directors-unanimously-approve-positioning-pearsanta-for-ipo-to-support-global-launch-of-its-early-cancer-detection-platform\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aditxts-board-of-directors-unanimously-approve-positioning-pearsanta-for-ipo-to-support-global-launch-of-its-early-cancer-detection-platform\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aditxts-board-of-directors-unanimously-approve-positioning-pearsanta-for-ipo-to-support-global-launch-of-its-early-cancer-detection-platform\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20250113994472r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20250113994472r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aditxts-board-of-directors-unanimously-approve-positioning-pearsanta-for-ipo-to-support-global-launch-of-its-early-cancer-detection-platform\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Aditxt\u2019s Board of Directors Unanimously Approve Positioning Pearsanta for IPO to Support Global Launch of its Early Cancer Detection Platform\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Aditxt\u2019s Board of Directors Unanimously Approve Positioning Pearsanta for IPO to Support Global Launch of its Early Cancer Detection Platform - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/aditxts-board-of-directors-unanimously-approve-positioning-pearsanta-for-ipo-to-support-global-launch-of-its-early-cancer-detection-platform\/","og_locale":"en_US","og_type":"article","og_title":"Aditxt\u2019s Board of Directors Unanimously Approve Positioning Pearsanta for IPO to Support Global Launch of its Early Cancer Detection Platform - Market Newsdesk","og_description":"Aditxt\u2019s Board of Directors Unanimously Approve Positioning Pearsanta for IPO to Support Global Launch of its Early Cancer Detection Platform MOUNTAIN VIEW, Calif.&#8211;(BUSINESS WIRE)&#8211; Aditxt, Inc. (NASDAQ: ADTX) (\u201cAditxt\u201d or the \u201cCompany\u201d), a social innovation platform dedicated to accelerating promising health innovations, is pleased to announce that its Board of Directors has authorized management to explore taking its subsidiary, Pearsanta, Inc. (\u201cPearsanta\u201d), public via a proposed initial public offering (\u201cIPO\u201d) in 2025. This decision aligns with Aditxt&#8217;s mission to secure and develop transformative health innovations, positioning them for accelerated growth and broader market impact. Pearsanta, a precision diagnostic company, has advanced its development and operational capabilities, particularly in early cancer detection, by leveraging its proprietary Mitomic\u00ae Technology platform. The proposed &hellip; Continue reading \"Aditxt\u2019s Board of Directors Unanimously Approve Positioning Pearsanta for IPO to Support Global Launch of its Early Cancer Detection Platform\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/aditxts-board-of-directors-unanimously-approve-positioning-pearsanta-for-ipo-to-support-global-launch-of-its-early-cancer-detection-platform\/","og_site_name":"Market Newsdesk","article_published_time":"2025-01-13T13:18:09+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250113994472r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aditxts-board-of-directors-unanimously-approve-positioning-pearsanta-for-ipo-to-support-global-launch-of-its-early-cancer-detection-platform\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aditxts-board-of-directors-unanimously-approve-positioning-pearsanta-for-ipo-to-support-global-launch-of-its-early-cancer-detection-platform\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Aditxt\u2019s Board of Directors Unanimously Approve Positioning Pearsanta for IPO to Support Global Launch of its Early Cancer Detection Platform","datePublished":"2025-01-13T13:18:09+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aditxts-board-of-directors-unanimously-approve-positioning-pearsanta-for-ipo-to-support-global-launch-of-its-early-cancer-detection-platform\/"},"wordCount":1027,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aditxts-board-of-directors-unanimously-approve-positioning-pearsanta-for-ipo-to-support-global-launch-of-its-early-cancer-detection-platform\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250113994472r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aditxts-board-of-directors-unanimously-approve-positioning-pearsanta-for-ipo-to-support-global-launch-of-its-early-cancer-detection-platform\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/aditxts-board-of-directors-unanimously-approve-positioning-pearsanta-for-ipo-to-support-global-launch-of-its-early-cancer-detection-platform\/","name":"Aditxt\u2019s Board of Directors Unanimously Approve Positioning Pearsanta for IPO to Support Global Launch of its Early Cancer Detection Platform - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aditxts-board-of-directors-unanimously-approve-positioning-pearsanta-for-ipo-to-support-global-launch-of-its-early-cancer-detection-platform\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aditxts-board-of-directors-unanimously-approve-positioning-pearsanta-for-ipo-to-support-global-launch-of-its-early-cancer-detection-platform\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250113994472r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2025-01-13T13:18:09+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aditxts-board-of-directors-unanimously-approve-positioning-pearsanta-for-ipo-to-support-global-launch-of-its-early-cancer-detection-platform\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/aditxts-board-of-directors-unanimously-approve-positioning-pearsanta-for-ipo-to-support-global-launch-of-its-early-cancer-detection-platform\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aditxts-board-of-directors-unanimously-approve-positioning-pearsanta-for-ipo-to-support-global-launch-of-its-early-cancer-detection-platform\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250113994472r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250113994472r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aditxts-board-of-directors-unanimously-approve-positioning-pearsanta-for-ipo-to-support-global-launch-of-its-early-cancer-detection-platform\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Aditxt\u2019s Board of Directors Unanimously Approve Positioning Pearsanta for IPO to Support Global Launch of its Early Cancer Detection Platform"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/799988","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=799988"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/799988\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=799988"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=799988"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=799988"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}